• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ICU Medical, Inc. - Common Stock (NQ:ICUI)

    118.81 +0.55 (+0.47%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about ICU Medical, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    ICU Medical Earnings Perspective: Return On Capital Employed
     
    Via Benzinga
    ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 Guidance
    From ICU Medical, Inc.
    Via GlobeNewswire
    ICU Medical to Present at the Raymond James 44th Annual Institutional Investors Conference
    From ICU Medical, Inc.
    Via GlobeNewswire
    ICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference Call
    From ICU Medical, Inc.
    Via GlobeNewswire
    ICU Medical's Return On Capital Employed Insights
     
    Via Benzinga
    FDA Signals Shortage Of ICU Medical's Tracheostomy Tubes
     
    Via Benzinga
    Smiths Acquisition Weighs On ICU Medical's Profitability, Shares Fall
     
    Via Benzinga
    Earnings Scheduled For February 27, 2023
    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
    Via Benzinga
    ICU Medical's Earnings: A Preview
     
    Via Benzinga
    Expert Ratings for ICU Medical
      Analysts have provided the following ratings for ICU Medical (NASDAQ:ICUI) within the last quarter: 
    Via Benzinga
    ICU Medical to Present at the J.P. Morgan 41st Annual Healthcare Conference
    From ICU Medical, Inc.
    Via GlobeNewswire
    TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
    Via AB Newswire
    Topics Death Economy Stocks
    ICU Medical Announces Third Quarter 2022 Results
    The Company Reaffirms 2022 Fiscal Year Guidance 
    From ICU Medical, Inc.
    Via GlobeNewswire
    Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization From Next Year: Top Stories Tuesday, Nov. 01
    Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production 
    Via Benzinga
    ICU Medical: Q2 Earnings Insights
      ICU Medical (NASDAQ:ICUI) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock
     
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
    Upgrades 
    Via Benzinga
    ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call
    From ICU Medical, Inc.
    Via GlobeNewswire
    Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
    Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading. 
    Via Benzinga
    Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
    U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
    Via Benzinga
    This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
    Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in... 
    Via Benzinga
    ICU Medical's Return On Capital Employed Insights
    ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million. 
    Via Benzinga
    Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
    Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
    Via Benzinga
    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
    Via Benzinga
    Morgan Stanley And 2 Other Stocks Insiders Are Buying
    Although US stocks closed sharply higher on Friday, there were a few notable insider trades. 
    Via Benzinga
    10 Biggest Price Target Changes For Tuesday
    Keybanc cut PubMatic, Inc. (NASDAQ: PUBM) price target from $48 to $27. PubMatic shares fell 1.5% to $18.71 in pre-market trading. 
    Via Benzinga
    The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
    Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
    Via Benzinga
    UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
    Health care stocks have some advantages in the current market environment. 
    Via Investor's Business Daily
    Recap: ICU Medical Q4 Earnings
    ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ICU... 
    Via Benzinga
    The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.